O
DEAD

Serial Number

76444457

Owner

Micromet AG

Attorney

John Christopher

Filing Date

Aug 28, 2002

Add to watchlist:

No watchlists yet
View on USPTO

O Trademark

Serial Number: 76444457 • Registration: 2912020

O is a trademark filed by Micromet AG on August 28, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Micromet AG (7 trademarks)

Staffelseestr. 2

Entity Type: 09

Trademark Details

Filing Date

August 28, 2002

Registration Date

December 21, 2004

Published for Opposition

September 28, 2004

Cancellation Date

July 24, 2015

Goods & Services

[ Diagnostic and testing apparatus, systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, Fluorescence Activated Cell Sorting FACS devices, lasers, balloon instruments, magnetic devices, all for scientific research purposes, development of medicaments, identification and analysis of eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides ]

[ Medicaments, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases, preparations for clinical diagnosis and analysis of animal and human diseases for clinical medical use; eukaryotic cells, eukaryotic cell culture lines, animal and human material in the nature of cells out of cell culture, and of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Fluorescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissues, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for medical purposes, namely, for use in the treatment of tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; sanitary preparations for medical purposes, namely, pharmaceutical agents for dental care ]

[Chemical preparations, namely, buffers, polypeptides, nucleic acids for scientific research purposes, water-oil solutions, chemical preparations in the form of powders, chemical preparations in the form of ointments, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, and chemical additives, all for scientific research purposes; chemical agents, namely, polypeptides, nucleic acids for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with Flourescence Activated Cell Sorting devices FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes; eukaryotic cells, eukaryotic cell culture lines, microorganisms, nucleic acids, polypeptides, animal and human material in the nature of cells out of cell culture, of cells of microscopic small biopsies of animal and human tissues, of cells out of tissue samples prepared with a laser, of cells isolated with FACS or with receptor/ligand binding, of cells of chemically fixed tissue, of micrometastatic cells, of bone marrow cells, of samples from body fluids, of stem cells, cloned single cells or differentiated stages from specific cells, all for scientific research purposes ]

[ Diagnostic and testing apparatus, systems and instruments in the nature of syringes, needles, biopsy needles, DNA-array devices, RNA-array devices, array readers, scanners, imaging devices, hybridization machines, hybridization chambers, thermocyclers, centrifuges, reaction tubes, centrifuge tubes, filters, rotators, mixers, beads, Flourescence Activated Cell Sorting devices FACS, lasers, balloon instruments, magnetic devices, all for clinical medical purposes, clinical diagnosis and analysis for animal and human diseases, eukaryotic cells, eukaryotic cell culture lines and animal and human material ]

Scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, in the field of molecular biology, biotechnology, genetics, medicine, pharmacology, cell biology; identification of target structures for the development of medicaments, identification of cell growth and differentiation; determination of the pathogenesis of animal and human diseases; development of medicaments; development of technologies and means for scientific research and industrial, medical, pharmaceutical, chemical, biological, biochemical, biotechnological research, namely, of eukaryotic cells, eukaryotic cell culture lines, animal and human material, nucleic acids and polypeptides; performance of diagnoses and analyses of animal and human diseases for medical research purposes; eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jul 24, 2015 CAEX
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Aug 1, 2011 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 1, 2011 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 1, 2011 APRE
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jun 20, 2011 815F
TEAS SECTION 8 & 15 RECEIVED
Jun 20, 2011 E815
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 24, 2010 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 24, 2010 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 2, 2005 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 20, 2005 TCCA
REGISTERED-PRINCIPAL REGISTER
Dec 21, 2004 R.PR
PUBLISHED FOR OPPOSITION
Sep 28, 2004 PUBO
NOTICE OF PUBLICATION
Sep 8, 2004 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2004 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2004 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 25, 2004 CRFA
PAPER RECEIVED
May 25, 2004 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 3, 2004 CRFA
PAPER RECEIVED
May 3, 2004 MAIL
FINAL REFUSAL MAILED
Dec 1, 2003 CNFR
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Nov 17, 2003 UNPR
PAPER RECEIVED
Nov 17, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2003 CRFA
PAPER RECEIVED
Oct 10, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 7, 2003 CRFA
NON-FINAL ACTION MAILED
Sep 15, 2003 CNRT
CASE FILE IN TICRS
Aug 5, 2003 CFIT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2003 CRFA
PAPER RECEIVED
Jun 23, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2003 CRFA
PAPER RECEIVED
May 16, 2003 MAIL
NON-FINAL ACTION MAILED
Dec 10, 2002 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2002 DOCK